—
C+
C+ The full Closelooknet — membership. Open the C+ overview

GSK plc (GSK) — Technical state

As of 2026-11-10 — re-computed nightly across the coverage universe. Closelooknet diary readings, not advice.

The Closelooknet read

  • Closelooknet score: 55 out of 100 (momentum 54 · quality 78 · valuation 54), as of 2026-11-11.
  • Signal: Recovery attempt under the 200-day — Trades +3.9% vs the 50-day and -1.2% vs the 200-day average, 14.8% below the 52-week high and +14.8% off the 52-week low; a death cross printed 49 sessions ago. Computed from daily closes. (as of 2026-11-10)
  • Trend: GSK plc trades 3.9% above its 50-day and 1.2% below its 200-day moving average. (as of 2026-11-10)

GSK researches, develops and manufactures vaccines and medicines through two segments, Commercial Operations and Total R&D. It sells specialty medicines for oncology, respiratory conditions and immune disease, vaccines against shingles, meningitis, RSV and other infections, and general medicines for asthma and COPD.

The full read — the desk's view, the earnings record, peers and the company snapshot — is on the GSK overview. Agents can buy the score depth per call over HTTP 402 — see the catalogue. Research diary readings, not advice.

Recovery attempt under the 200-day

Trades +3.9% vs the 50-day and -1.2% vs the 200-day average, 14.8% below the 52-week high and +14.8% off the 52-week low; a death cross printed 49 sessions ago. Computed from daily closes.

The moving-average stack

Continue: the GSK chart & overview · quality & forensics · the earnings record · the signal board

FAQ · from the current data · as of 2026-11-10

Quick answers

What is the current Closelooknet signal on GSK?

Recovery attempt under the 200-day — Trades +3.9% vs the 50-day and -1.2% vs the 200-day average, 14.8% below the 52-week high and +14.8% off the 52-week low; a death cross printed 49 sessions ago. Computed from daily closes. As of 2026-11-10; the signal board re-computes across the coverage universe nightly. A research diary reading, not advice.

Is GSK above its 50-day and 200-day moving averages?

As of 2026-11-10, GSK plc trades +3.9% above its 50-day and -1.2% below its 200-day average, with the 20-day +2.5% away.

How far is GSK from its 52-week high?

14.8% below the 52-week high and 14.8% above the 52-week low, as of 2026-11-10.

Related in the Closelooknet universe

then Drug Manufacturers - General, then Healthcare. Scored names rank on their Closelooknet score; names without one rank on trend state — above or below their 50- and 200-day averages — never on a score they do not carry.